Primary antiphospholipid syndrome: A low-grade auto-inflammatory disease?

P. R.J. Ames, I. Antinolfi, A. Ciampa, J. Batuca, G. Scenna, L. R. Lopez, J. Delgado Alves, L. Iannaccone, E. Matsuura

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Objective. To test the inflammation and immune activation hypothesis in primary thrombotic APS (PAPS) and to identify clinical and laboratory factors related to inflammation and immune activation. Methods. PAPS (n = 41) patients were compared with patients with inherited thrombophilia (IT, n = 44) and controls (CTR, n = 39). IgG aCL, IgG anti-β2-glycoprotein I (β2GPI), high-sensitivity CRP (hs-CRP), serum amyloid A (SAA), CRP bound to oxidized low-density lipoprotein-β2GPI complex (CRP-oxLDL-β2 GPI) (as inflammatory markers) neopterin (NPT), soluble CD14 (sCD14) (as immune activation markers) were measured by ELISA. Results. After correction for confounders, PAPS showed higher plasma levels of hs-CRP (P = 0.0004), SAA (P = 0.01), CRP-oxLDL-β2GPI (P = 0.0004), NPT (P = 0.0001) and sCD14 (P = 0.007) than IT and CTR. Two regression models were applied to the PAPS group: in the first, IgG aCL and IgG β2GPI were included amongst the independent variables and in the second they were excluded. In the first model, SAA (as the dependent variable) independently related to thrombosis number (P = 0.003); NPT (as the dependent variable) independently related to thrombosis type (arterial, P = 0.03) and number (P = 0.04); sCD14 (as the dependent variable) independently related to IgG β2 GPI (P = 0.0001), age (0.001) and arterial thrombosis (P = 0.01); CRP-oxLDL-β2 GPI (as the dependent variable) independently related to IgG β2GPI (P = 0.0001). In the second model, sCD14 and NPT independently related to each other (P = 0.002) (this was noted also in the IT group, P = 0.0001) and CRP-oxLDL-β2GPI independently predicted SAA (P = 0.002). Conclusion. Low-grade inflammation and immune activation occur in thrombotic PAPS and relate to clinical features and aPL levels.

Original languageEnglish
Pages (from-to)1832-1837
Number of pages6
JournalRheumatology
Volume47
Issue number12
DOIs
Publication statusPublished - Nov 28 2008

Keywords

  • Anti-phospholipid syndrome
  • C-reactive protein
  • Neopterin
  • Serum amyloid A
  • Soluble CD14

ASJC Scopus subject areas

  • Rheumatology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Primary antiphospholipid syndrome: A low-grade auto-inflammatory disease?'. Together they form a unique fingerprint.

  • Cite this

    Ames, P. R. J., Antinolfi, I., Ciampa, A., Batuca, J., Scenna, G., Lopez, L. R., Delgado Alves, J., Iannaccone, L., & Matsuura, E. (2008). Primary antiphospholipid syndrome: A low-grade auto-inflammatory disease? Rheumatology, 47(12), 1832-1837. https://doi.org/10.1093/rheumatology/ken382